Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Arbutus Biopharma Corp
Swot
Arbutus Biopharma Corp SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Arbutus Biopharma Corp has 5 Strengths, 10 Weaknesses, 5 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(5)
Weakness
(10)
Opportunity
(5)
Threats
(0)
Others
(0)
Annual Profit Growth higher than Sector Profit Growth
Relative Outperformance versus Industry over 1 Week
Company with Low Debt
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Stock with Low PE (PE < = 10)
Promoter decreasing their shareholding
Promoter holding decreased by more than -2% QoQ
Negative profit growth, promoters decreasing shareholding QoQ
PEG greater than Industry PEG
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Low Piotroski Score : Companies with weak financials
Book Value Per Share deteriorating for last 2 years
Stocks Underperforming their Industry Price Change in the Quarter
Mutual Funds Increased Shareholding in Past Month
Institutions increasing their shareholding
Mutual Funds Increased Shareholding over the Past Two Months
MFs increased their shareholding last quarter
Mf buying for 2 months